Nurix Therapeutics, Inc.

Historical 13F Holders

Symbol
NRIX
CUSIP
67080M103
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 67080M103 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 8.2% 4/23/2025
Event 3/31/2025
Baker Bros. Advisors LP 13G/A
7.2% 2/17/2026
Event 12/31/2025
Vestal Point Capital, LP 13G/A
6.4% 11/16/2026
Event 9/30/2026
Deep Track Capital, LP 13G/A
5.5% 11/16/2026
Event 9/30/2026
Vanguard Capital Management LLC 13G 5.0% 7/31/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (9)
Redmile Group, LLC 13G/A
8.1%
Checked 5% or less
8/14/2026
Event 6/30/2026
Perceptive Advisors LLC 13G/A
4.9% 11/16/2026
Event 9/30/2026
Commodore Capital LP 13G/A
4.9% 11/14/2025
Event 9/30/2025
Rubric Capital Management LP 13G/A
4.6% 11/16/2026
Event 9/30/2026
Price T Rowe Associates Inc /MD/ 13G/A 4.4% 11/16/2026
Event 9/30/2026
FMR LLC 13G/A
4.2% 11/5/2026
Event 9/30/2026
Wellington Management Group LLP 13G/A
4.2% 5/12/2025
Event 3/31/2025
ARK Investment Management LLC 13G/A 0% 1/10/2025
Event 9/30/2024
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 236 120 M $2.84B
2026 Q2 214 117 M $2.85B
2026 Q1 197 117 M $1.81B
2025 Q4 185 114 M $2.15B
2025 Q3 174 84.8 M $783M
2025 Q2 166 88.3 M $1.01B
2025 Q1 172 84.6 M $1.01B
2024 Q4 177 81.1 M $1.53B
2024 Q3 174 67.9 M $1.53B
2024 Q2 176 65.0 M $1.36B
2024 Q1 141 49.1 M $721M
2023 Q4 131 46.1 M $476M
2023 Q3 131 44.8 M $352M
2023 Q2 128 43.6 M $436M
2023 Q1 125 42.5 M $377M
2022 Q4 121 42.7 M $469M
2022 Q3 120 43.1 M $561M
2022 Q2 109 45.0 M $568M
2022 Q1 119 40.4 M $566M
2021 Q4 127 40.4 M $1.17B
2021 Q3 115 39.5 M $1.18B
2021 Q2 105 39.5 M $1.05B
2021 Q1 103 41.3 M $1.29B
2020 Q4 69 33.1 M $1.09B
2020 Q3 67 31.9 M $1.11B